These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8356789)

  • 1. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN; Felber BK
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    Benko DM; Schwartz S; Pavlakis GN; Felber BK
    J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
    Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
    Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling elements in replication of the human immunodeficiency virus type 1.
    Li X; Quan Y; Wainberg MA
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat and Rev: positive regulators of HIV gene expression.
    Rosen CA; Pavlakis GN
    AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316
    [No Abstract]   [Full Text] [Related]  

  • 19. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Malim MH; Hauber J; Le SY; Maizel JV; Cullen BR
    Nature; 1989 Mar; 338(6212):254-7. PubMed ID: 2784194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RNA ligands for HIV proteins].
    Iwai S
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.